Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors

Journal of Hematotherapy and Stem Cell Research

Volumn 10, Issue 1, 2001, Pages 177-186

  Gazitt, Y ^a   Shaughnessy, P ^b   Devore, P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD56 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR;

ADULT; AGED; APHERESIS; ARTICLE; BIOLOGICAL THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; CELL DIVISION; DENDRITIC CELLS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035086677     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581601750098471     Document Type: Article

References (42)

1. Characterization of chemotherapy mobilized peripheral blood projenitor cells for use in autologous stem cell transplantation
2. Factors affecting blood stem cell collection following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors
3. Transplantation potential of peripheral blood stem cells induced by G-CSF
4. Optimization of stem cell mobilization
5. Transplantation of hematopoietic cells released into the peripheral blood for non-Hodgkin's lymphoma
6. Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: Risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration
7. Granulocyte colony stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high dose chemotherapy
8. Comparative effect of GM-CSF and G-CSF on priming of peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy
9. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation
10. Successful PBSC mobilization with high dose G-CSF for patients failing a first round of mobilization
11. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and GM-CSF
12. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: An analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma
13. + cells mobilized by G-CSF
14. Harvesting and enrichment of HPC mobilized into the peripheral blood of normal donors by GM-CSF or G-CSF: Potential role in allogeneic transplantation
15. Composition of peripheral blood progenitor cell components collected from healthy donors
16. Phase I/II study of combined G-CSF and GM-CSF administration for the mobilization of hematopoietic progenitor cells
17. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: Effects on hematopoietic recovery after high-dose chemotherapy
18. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells
19. Peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF, or sequential GM-CSF followed by G-CSF in non Hodgkin's lymphoma patients: A randomized prospective study
20. Comparison of monocyte dependent T cell inhibitory activity in GM-CSF vs. G-CSF mobilized PSC products
21. Inhibitory effect of granulocyte-macrophage colony-stimulating factor therapy on the generation of natural killer cells
22. Suppression of natural killer cell activity by granulocytes in patients with aplastic anemia: Role of granulocyte colony stimulating factor
23. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells
24. Natural killer cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections
25. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: Conditions for in vitro expansion
26. Suppressive effect of granulocyte macrophage stimulating factor on the generation of natural killer cells in vitro
27. Functional and phenotypic characterization of human peripheral blood stem cells: A comparative analysis of cells from consecutive collections
28. Immunological phenotype and function in human bone marrow stem cells and umbilical cord blood
29. Dendritic cells: Unique leukocyte population which control primary immune response
30. Human CD14 Leukocytes acquire the phenotype and function of antigen presenting dendritic cells when cultured in GM-CSF and IL-4
31. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
32. + cells
33. + cells
34. CD1 expression on human monocytes induced by GM-CSF
35. Involvement of CD80 in the generation of cytotoxic T cells
36. Dendritic cell based vaccine: A promising approach for cancer immunotherapy
37. Development of dendritic cells and their use in tumor therapy
38. A randomized study of peripheral blood stem cell mobilization with cyclophosphamide in combination with G-CSF, GM-CSF and sequential GM-CSF followed by G-CSF in non-Hodgkin's lymphoma patients: Co-mobilization of dendritic cells and NK-cells
39. Interferon induced cytotoxicity and (2′-5′) oligo A synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T cell lines
40. Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients
41. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation
42. A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy